Victory Capital Management
ATRA icon

Victory Capital Management’s Atara Biotherapeutics ATRA Stock Holding History

Victory Capital Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-422
Closed -$15.6K – 2542
2023
Q3 		$15.6K Buy
422
+19
+5% +$846 ﹤0.01% 2462
2023
Q2 		$16.2K Sell
403
-10
-2% -$565 ﹤0.01% 2459
2023
Q1 		$29.9K Buy
413
+2
+0.5% +$194 ﹤0.01% 2483
2022
Q4 		$33.7K Hold
411
– – ﹤0.01% 2483
2022
Q3 		$39K Sell
411
-46
-10% -$5.17K ﹤0.01% 2582
2022
Q2 		$89K Buy
457
+17
+4% +$2.77K ﹤0.01% 2471
2022
Q1 		$70K Sell
440
-13
-3% -$4.14K ﹤0.01% 2562
2021
Q4 		$178K Buy
453
+11
+2% +$4.63K ﹤0.01% 2504
2021
Q3 		$198K Sell
442
-51
-10% -$18.3K ﹤0.01% 2528
2021
Q2 		$192K Sell
493
-12
-2% -$4.28K ﹤0.01% 2532
2021
Q1 		$181K Sell
505
-19
-4% -$8.4K ﹤0.01% 2536
2020
Q4 		$257K Buy
524
+80
+18% +$36.9K ﹤0.01% 2326
2020
Q3 		$144K Sell
444
-9
-2% -$3.06K ﹤0.01% 2320
2020
Q2 		$165K Buy
453
+76
+20% +$19.2K ﹤0.01% 2322
2020
Q1 		$80K Sell
377
-38
-9% -$12.1K ﹤0.01% 2378
2019
Q4 		$171K Buy
415
+99
+31% +$34.1K ﹤0.01% 2349
2019
Q3 		$112K Buy
+316
New +$118K ﹤0.01% 2399

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management's ATRA Position: Q4 2023 in Review

Victory Capital Management sold out of Atara Biotherapeutics (ATRA) in Q4 2023, closing a stake of 422 shares — an estimated $15.6K sold.

Victory Capital Management first reported a position in ATRA in Q3 2019 and held it in 17 quarters. The position peaked at $257K in Q4 2020. 90 funds tracked by Wall St. Rank hold ATRA as of Q4 2023.

  • Victory Capital Management reported no remaining Atara Biotherapeutics position as of Q4 2023 after selling out during the quarter.
  • Victory Capital Management sold 422 Atara Biotherapeutics shares in Q4 2023, an estimated $15.6K.
  • Victory Capital Management first reported a position in Atara Biotherapeutics in Q3 2019 and held it in 17 quarters.
  • Victory Capital Management's Atara Biotherapeutics position peaked at $257K in Q4 2020.
  • 90 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q4 2023.

Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.